Literature DB >> 8871712

Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia.

H R Jäger1, E J Williams, D G Savage, S A Rule, J V Hajnal, K Sikora, J M Goldman, G M Bydder.   

Abstract

PURPOSE: To determine the frequency and nature of changes to the brain resulting from chemotherapy, radiation therapy, and bone marrow transplantation for chronic myeloid leukemia and to compare the sensitivity of conventional and registered MR scans for detecting these changes.
METHODS: In 15 patients, conventional T1-weighted, T2-weighted, and fluid-attenuated inversion recovery MR sequences, as well as T1-weighted radio frequency spoiled 3-D volume MR scans were performed before, 4 to 6 days after, and up to 339 days after transplantation (13 allografts, two autografts). A subvoxel registration program was used to match the volume images precisely so that small changes could be detected after subtraction of scans. Five healthy adult control subjects were also studied on two occasions 1 month apart.
RESULTS: Studies performed 4 to 339 days after transplantation showed ventricular enlargement and cortical atrophy in all 13 patients who had allografts. The changes were evident at 4 to 6 days after transplantation and became more obvious during later follow-up examinations. Similar changes were seen in one patient with an autograft but no significant change was seen in the other patient with an autograft or in the five control subjects. Accurately registered volume scans were more sensitive than unregistered conventional scans in detecting early (9/10 versus 0/10), intermediate (12/13 versus 3/12), and late (10/10 versus 4/9) ventricular enlargement on follow-up examinations. The same applied to cortical atrophy (9/10 versus 0/10, 12/13 versus 0/12, and 10/10 versus 0/9).
CONCLUSION: The specific cause and clinical significance of these changes are uncertain. Subvoxel registration of serial MR images may reveal changes that are poorly seen or not apparent on conventional scans.

Entities:  

Mesh:

Year:  1996        PMID: 8871712      PMCID: PMC8338537     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  4 in total

1.  Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation.

Authors:  Anne C Kirchhoff; Wendy Leisenring; Karen L Syrjala
Journal:  J Cancer Surviv       Date:  2010-03       Impact factor: 4.442

2.  A three-year study of brain atrophy after autologous hematopoietic stem cell transplantation in rapidly evolving secondary progressive multiple sclerosis.

Authors:  M A Rocca; T Mondria; P Valsasina; M P Sormani; Z H Flach; P A Te Boekhorst; G Comi; R Q Hintzen; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

3.  Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results.

Authors:  J D Bowen; G H Kraft; A Wundes; Q Guan; K R Maravilla; T A Gooley; P A McSweeney; S Z Pavletic; H Openshaw; R Storb; M Wener; B A McLaughlin; G R Henstorf; R A Nash
Journal:  Bone Marrow Transplant       Date:  2011-11-07       Impact factor: 5.483

4.  High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

Authors:  Richard A Nash; George J Hutton; Michael K Racke; Uday Popat; Steven M Devine; Kaitlyn C Steinmiller; Linda M Griffith; Paolo A Muraro; Harry Openshaw; Peter H Sayre; Olaf Stuve; Douglas L Arnold; Mark H Wener; George E Georges; Annette Wundes; George H Kraft; James D Bowen
Journal:  Neurology       Date:  2017-02-01       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.